Issue 2/2020
Content (9 Articles)
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
HoUng Kim, Rieke Alten, Luisa Avedano, Axel Dignass, Fernando Gomollón, Kay Greveson, Jonas Halfvarson, Peter M. Irving, Jørgen Jahnsen, Péter L. Lakatos, JongHyuk Lee, Souzi Makri, Ben Parker, Laurent Peyrin-Biroulet, Stefan Schreiber, Steven Simoens, Rene Westhovens, Silvio Danese, Ji Hoon Jeong
Emerging Challenges to the Safe and Effective Use of Methadone for Cancer-Related Pain in Paediatric and Adult Patient Populations
Kyle P. Edmonds, Ila M. Saunders, Andrew Willeford, Toluwalase A. Ajayi, Rabia S. Atayee
Poly (ADP-ribose) Polymerase Inhibition in Patients with Breast Cancer and BRCA 1 and 2 Mutations
Yolanda Jerez, Ivan Márquez-Rodas, Inmaculada Aparicio, Manuel Alva, Miguel Martín, Sara López-Tarruella
Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes
Stewart Harris, Martin J. Abrahamson, Antonio Ceriello, Guillaume Charpentier, Marc Evans, Roger Lehmann, Andreas Liebl, Sultan Linjawi, Richard I. G. Holt, Nóra Hosszúfalusi, Guy Rutten, Tina Vilsbøll
24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
E. Randy Craven, Thomas Walters, William C. Christie, Douglas G. Day, Richard A. Lewis, Margot L. Goodkin, Michelle Chen, Veronica Wangsadipura, Michael R. Robinson, Marina Bejanian, Tin Aung, Allen D. Beck, James D. Branch, William C. Christie, Michael Coote, Charles J. Crane, E. Randy Craven, Andrew Crichton, Douglas G. Day, Steven Day, F. Jane Durcan, Richard M. Evans, William J. Flynn, Sébastien Gagné, Damien F. Goldberg, Jack V. Greiner, Paul Jeppsen, Delan Jinapriya, C. Starck Johnson, Shimon Kurtz, Richard A. Lewis, Steven L. Mansberger, Joseph R. Martel, Shamira A. Perera, Michael H. Rotberg, Robert M. Saltzmann, Howard I. Schenker, Michael E. Tepedino, Maria Imelda R. Yap-Veloso, Harvey S. Uy, Thomas R. Walters
Ibalizumab: A Review in Multidrug-Resistant HIV-1 Infection
Hannah A. Blair